Clotilde Allavena

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 246 citations · Full text

Opportunistic infections occurring during highly active antiretroviral treatment

C. Michelet, C. Arvieux, Cécile François et al. · AIDS · 1998 · 183 citations

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor

Sophie Grabar, Christian Pradier, Emmanuelle Le Corfec et al. · AIDS · 2000 · 177 citations

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G. Babiker, Laura Richert et al. · The Lancet · 2014 · 172 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +10

A large French prospective cohort of HIV‐infected patients: the Nadis Cohort

P. Puglièse, L Cuzin, André Cabié et al. · HIV Medicine · 2009 · 126 citations · Full text